D-0931-2022 Class II

Recalled by Olympia Compounding Pharmacy Dba Olympia Pharmacy — Orlando, FL

FDA drug recall D-0931-2022 was initiated by Olympia Compounding Pharmacy Dba Olympia Pharmacy on May 9, 2022 and is designated Class II. Reason for recall: Lack of assurance of sterility. Affected quantity: 310 vials.

Recall Details

Product Type
Drugs
Report Date
Jun 1, 2022
Initiation Date
May 9, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
310 vials

Product Description

Lidocaine 1%/Epinephrine 1:100,000/mL, Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0099-30

Reason for Recall

Lack of assurance of sterility.

Distribution Pattern

Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands

Code Information

Lot: K41023 BUD: 5/23/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0931-2022
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.